Drug-induced pancreatitis is a rare but important cause of pancreatic injury. Orlistat is a pancreatic lipase inhibitor licensed for the treatment of obesity. We present a case of orlistat- induced mild acute pancreatitis that developed 8 days after starting treatment.
Carriere F, Renou C, Ransac S, et al. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volun- teers. Am J Physiol Gastrointest Liver Physiol 2001; 281: G16-28.
ilaca bağlı pankreatit vakaları nadirdir, fakat önemli derecelerde pankreatik hasara sebep olabilirler. Orlistat, obezite tedavisinde kullanılan pankreatik lipaz inhibitörüdür. Orlistat ile obezite tedavisine başlandıktan sonraki 8. günde gözlenen hafif derecede akut pankreatit vakasını sunduk.
Carriere F, Renou C, Ransac S, et al. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volun- teers. Am J Physiol Gastrointest Liver Physiol 2001; 281: G16-28.
Şimşek, Z., Altınbaş, A., Doğan, H. K., Dilli, A., vd. (2012). Orlistat tedavisine bağlı akut pankreatit. Akademik Gastroenteroloji Dergisi, 11(2), 90-91.